← Back to Screener
EDAP TMS SA (EDAP)
Price$4.32
Value ScoreC
Growth ScoreB
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)67.12%
Price vs S&P 500 (4W)19.52%
VGM Score58.39
Market Capitalization$188.69M
All Metrics
Book Value / Share (Quarterly)$0.31
P/TBV (Annual)6.81x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)16.97%
Cash Flow / Share (Quarterly)$-0.61
Price vs S&P 500 (YTD)20.37%
Gross Margin (TTM)46.63%
Net Profit Margin (TTM)-44.51%
EPS (TTM)$-0.97
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.97
Revenue Growth (5Y)9.45%
EPS (Annual)$-0.91
ROI (Annual)-66.44%
Gross Margin (Annual)42.54%
Net Profit Margin (5Y Avg)-18.06%
Cash / Share (Quarterly)$0.47
Revenue Growth QoQ (YoY)31.38%
ROA (Last FY)-37.02%
Revenue Growth TTM (YoY)9.65%
EBITD / Share (TTM)$-0.67
ROE (5Y Avg)-47.80%
Operating Margin (TTM)-37.25%
Cash Flow / Share (Annual)$-0.69
P/B Ratio16.03x
P/B Ratio (Quarterly)13.80x
Net Income / Employee (Annual)$-117,931
EV / Revenue (TTM)2.46x
Net Interest Coverage (TTM)-17.72x
ROA (TTM)-40.94%
EV / EBITDA (TTM)373.64x
EPS Incl Extra (Annual)$-0.91
Current Ratio (Annual)1.54x
Quick Ratio (Quarterly)0.99x
3-Month Avg Trading Volume0.05M
52-Week Price Return141.34%
Revenue / Employee (TTM)$281,192
Tangible BV / Share (Quarterly)$0.26
P/S Ratio (Annual)2.30x
Asset Turnover (Annual)0.89x
52-Week High$5.05
Operating Margin (5Y Avg)-16.75%
EPS Excl Extra (Annual)$-0.91
CapEx CAGR (5Y)55.18%
Tangible BV CAGR (5Y)-7.13%
26-Week Price Return83.05%
Quick Ratio (Annual)1.16x
13-Week Price Return-2.37%
Total Debt / Equity (Annual)1.27x
Current Ratio (Quarterly)1.34x
Enterprise Value$200.29M
Revenue / Share Growth (5Y)4.44%
Asset Turnover (TTM)0.92x
Book Value / Share Growth (5Y)-10.48%
Revenue / Employee (Annual)$284,339
Inventory Turnover (Annual)2.53x
Pretax Margin (Annual)-40.85%
Cash / Share (Annual)$0.64
3-Month Return Std Dev57.29%
Gross Margin (5Y Avg)43.93%
Net Income / Employee (TTM)$-125,156
ROE (Last FY)-150.65%
Net Interest Coverage (Annual)-2.72x
EPS Basic Excl Extra (Annual)$-0.91
P/FCF (TTM)23.89x
Receivables Turnover (TTM)3.89x
Total Debt / Equity (Quarterly)2.47x
EPS Incl Extra (TTM)$-0.97
Receivables Turnover (Annual)3.47x
ROI (TTM)-80.27%
P/S Ratio (TTM)2.32x
Pretax Margin (5Y Avg)-17.06%
Revenue / Share (Annual)$2.20
Tangible BV / Share (Annual)$0.55
Price vs S&P 500 (52W)113.13%
Year-to-Date Return31.31%
5-Day Price Return0.47%
EPS Normalized (Annual)$-0.91
ROA (5Y Avg)-17.03%
Net Profit Margin (Annual)-41.47%
Month-to-Date Return30.12%
EBITD / Share (Annual)$-0.66
Operating Margin (Annual)-35.01%
LT Debt / Equity (Annual)0.82x
ROI (5Y Avg)-28.02%
LT Debt / Equity (Quarterly)1.74x
EPS Basic Excl Extra (TTM)$-0.97
P/TBV (Quarterly)16.64x
P/B Ratio (Annual)6.18x
Inventory Turnover (TTM)2.70x
Pretax Margin (TTM)-43.88%
Book Value / Share (Annual)$0.60
Price vs S&P 500 (13W)-12.12%
Beta0.01x
P/FCF (Annual)40.89x
Revenue / Share (TTM)$2.17
ROE (TTM)-138.72%
52-Week Low$1.21
vGradeC
gGradeB
mGradeB
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.89
3.89
3.89
3.89
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
EDAPEDAP TMS SA | C | B | B | $4.32 |
| MDTMedtronic plc | B | D | D | $73.98 |
| MASIMasimo Corporation | D | D | B | $178.59 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $73.81 |
| ITGRInteger Holdings Corporation | B | C | C | $90.16 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | F | $67.53 |
| AXGNAxogen, Inc. Common Stock | F | B | B | $38.72 |
| BLFSBioLife Solutions Inc. | F | B | B | $26.63 |
| CNMDCONMED Corporation | A | C | D | $34.65 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | $13.59 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $17.61 |
About
Edap TMS SA develops and markets ultrasound-based medical devices for urology and oncology, with three core divisions: HIFU technology for minimally invasive tumor treatment, ESWL systems for kidney stone lithotripsy, and a distribution channel for complementary medical products. The company generates revenue from both proprietary device sales and service of its global installed base across North America, Europe, and Asia.